notificationsアラート設定
~
検索条件をクリア

アブストラクト

Title 第1回 児童思春期に効果を認めない抗うつ薬たち
Subtitle 短期補講連載 児童精神科医が伝えたい 子どものメンタルヘルス
Authors 宇佐美政英
Authors (kana)
Organization 国立国際医療研究センター国府台病院子どものこころ総合診療センター長 / 児童精神科 診療科長
Journal 月刊薬事
Volume 65
Number 5
Page 965-970
Year/Month 2023 / 4
Article 報告
Publisher じほう
Abstract 「はじめに」抗うつ薬という名前はいまでこそ広く世間に知られていますが, 私が小さい頃(昭和)はこれほど知られてはいなかったと思います. そもそも精神科や発達障害などが大した話題になっていなかったのではないでしょうか. 令和の現代では, 街にメンタルクリニックがあふれ, 精神科への敷居は以前より低くなっているかもしれません. 実際, わが国の抗うつ薬の処方数は増加の一途をたどっています. 児童精神科臨床において, 抗うつ薬はまずうつ病に使われるとともに, 強迫性障害(obsessive compulsive disorder;OCD)を含めた不安障害でも使われます. しかし, よく聞かれることではありますが, 子どものうつ病は存在するのでしょうか. 海外の文献によれば, 推定有病率は5〜10歳で約0〜3%, 11〜16歳で2〜7%, 17〜19歳で4〜8%とされています.
Practice 薬学
Keywords
  • 全文ダウンロード： 従量制、基本料金制の方共に803円(税込) です。
download全文ダウンロード(2.22MB)

参考文献

  • 1) 奥村泰之, 他 : 日本における子どもへの向精神薬処方の経年変化 ; 2002年から2010年の社会医療診療行為別調査の活用. 精神神経学雑誌, 116 : 921-935, 2014
  • 2) Thapar A, et al : Depression in adolescence. Lancet, 379 : 1056-1067, 2012
    pubmed
  • 3) Moncrieff J, et al : Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemp Clin Trials, 43 : 60-62, 2015
    pubmed
  • 4) 日本うつ病学会・監 : うつ病治療ガイドライン第2版. 医学書院, 2017
  • 5) Zhou X, et al : Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder : a systematic review and network meta-analysis. Lancet Psychiatry, 7 : 581-601, 2020
    pubmed
残りの25件を表示する
  • 6) Brent D, et al : Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression : the TORDIA randomized controlled trial. JAMA, 299 : 901-913, 2008
  • 7) Goodyer I, et al : Selective serotonin reuptake inhibitors(SSRIs)and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression : randomised controlled trial. BMJ, 335 : 142, 2007
    pubmed
  • 8) Mathews M, et al : Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA, 291 : 40 ; author reply 42, 2004
    pubmed
  • 9) Watson HJ, et al : Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 49 : 489-498, 2008
    pubmed
  • 10) Locher C, et al : Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents : A systematic review and meta-analysis. JAMA Psychiatry, 74 : 1011-1020, 2017
    pubmed
  • 11) Wehry AM, et al : Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep, 17 : 52, 2015
    pubmed
  • 12) Strawn JR, et al : The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders : A Meta-Analysis. J Am Acad Child Adolesc Psychiatry, 57 : 235-244. e2, 2018
  • 13) Rynn MA, et al : Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry, 158 : 2008-2014, 2001
    pubmed
  • 14) Strawn JR, et al : A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry, 54 : 283-293, 2015
    pubmed
  • 15) Uthman OA, et al : Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents : a mixed treatment comparison meta-analysis. Curr Med Res Opin, 26 : 53-59, 2010
    pubmed
  • 16) Ginsburg GS, et al : Remission after acute treatment in children and adolescents with anxiety disorders : findings from the CAMS. J Consult Clin Psychol, 79 : 806-813, 2011
    pubmed
  • 17) Rynn MA, et al : Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents : two placebo-controlled trials. Am J Psychiatry, 164 : 290-300, 2007
    pubmed
  • 18) March JS, et al : A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry, 62 : 1149-1154, 2007
    pubmed
  • 19) Wagner KD, et al : A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry, 61 : 1153-1162, 2004
    pubmed
  • 20) Beidel DC, et al : SET-C versus fluoxetine in the treatment of childhood social phobia. J Am Acad Child Adolesc Psychiatry, 46 : 1622-1632, 2007
    pubmed
  • 21) Brent DA, et al : The Treatment of Adolescent Suicide Attempters study(TASA) : predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry, 48 : 987-996, 2009
  • 22) Dopheide JA : Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm, 63 : 233-243, 2006
    pubmed
  • 23) Hetrick SE, et al : New generation antidepressants for depression in children and adolescents : a network meta-analysis. Cochrane Database Syst Rev, 5 : CD013674, 2021
    pubmed
  • 24) Safer DJ : Age-grouped differences in adverse drug events from psychotropic medication. J Child Adolesc Psychopharmacol, 21 : 299-309, 2011
    pubmed
  • 25) Birmaher B, et al ; AACAP Work Group on Quality Issues : Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry, 46 : 1503-1526, 2007
  • 26) Southammakosane C, et al : Pediatric Psychopharmacology for Treatment of ADHD, Depression, and Anxiety. Pediatrics, 136 : 351-359, 2015
    pubmed
  • 27) Zhou X, et al : Systematic review of management for treat-ment-resistant depression in adolescents. BMC Psychiatry, 14 : 340, 2014
  • 28) Hammad TA, et al : Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry, 63 : 332-339, 2006
    pubmed
  • 29) Bridge JA, et al : Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric anti-depressant treatment : a meta-analysis of randomized controlled trials. JAMA, 297 : 1683-1696, 2007
  • 30) March J, et al ; Treatment for Adolescents With Depression Study(TADS)Team : Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression : Treatment for Adolescents With Depression Study(TADS)randomized controlled trial. JAMA, 292 : 807-820, 2004
    pubmed
はじめての方へ
個人／法人会員登録のご案内